Burcon NutraScience Statistics
Total Valuation
BRCND has a market cap or net worth of 29.19 million. The enterprise value is 34.44 million.
| Market Cap | 29.19M |
| Enterprise Value | 34.44M |
Important Dates
The next estimated earnings date is Thursday, June 26, 2025.
| Earnings Date | Jun 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 12.69M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +18.15% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 124.06 |
| PB Ratio | -510.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.13 |
| EV / Sales | 139.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.69 |
Financial Position
The company has a current ratio of 0.41
| Current Ratio | 0.41 |
| Quick Ratio | 0.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.21 |
| Interest Coverage | -14.75 |
Financial Efficiency
Return on equity (ROE) is -597.23% and return on invested capital (ROIC) is -59.85%.
| Return on Equity (ROE) | -597.23% |
| Return on Assets (ROA) | -54.84% |
| Return on Invested Capital (ROIC) | -59.85% |
| Return on Capital Employed (ROCE) | -133.93% |
| Revenue Per Employee | 9,412 |
| Profits Per Employee | -224,556 |
| Employee Count | 25 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -54,071 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 5,206 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRCND had revenue of 235,306 and -5.61 million in losses. Loss per share was -0.81.
| Revenue | 235,306 |
| Gross Profit | -223,134 |
| Operating Income | -5.27M |
| Pretax Income | -5.67M |
| Net Income | -5.61M |
| EBITDA | -5.04M |
| EBIT | -5.27M |
| Loss Per Share | -0.81 |
Balance Sheet
The company has 410,765 in cash and 5.42 million in debt, giving a net cash position of -5.01 million.
| Cash & Cash Equivalents | 410,765 |
| Total Debt | 5.42M |
| Net Cash | -5.01M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -57,156 |
| Book Value Per Share | -0.01 |
| Working Capital | -1.18M |
Cash Flow
In the last 12 months, operating cash flow was -4.31 million and capital expenditures -167,644, giving a free cash flow of -4.48 million.
| Operating Cash Flow | -4.31M |
| Capital Expenditures | -167,644 |
| Free Cash Flow | -4.48M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -94.83% |
| Operating Margin | -2,238.54% |
| Pretax Margin | -2,408.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRCND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.15% |
| Shareholder Yield | n/a |
| Earnings Yield | -19.23% |
| FCF Yield | -15.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 11, 2025. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 11, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
BRCND has an Altman Z-Score of -25.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.55 |
| Piotroski F-Score | 2 |